ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Interventional Cardiology

Top Interventional Cardiology Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KISHOR VORA M.D.

Interventional Cardiology

23,389

$1.56M

1710
1259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $58

ROGER KLEIN M.D.

Interventional Cardiology

14,484

$1.08M

562
475 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $58

AVICHAI ERES MD FACC FSCAI FSVM

Interventional Cardiology

12,921

$890K

863
614 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $58

GAYL READER M.D.

Interventional Cardiology

12,615

$883K

742
548 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $58

MOHIT SHETH M.D.

Interventional Cardiology

12,182

$630K

865
681 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

MUBASHIR QAZI MD FACC FSCAI

Interventional Cardiology

10,126

$612K

782
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $58

MICHAEL JARVIS M.D.

Interventional Cardiology

10,029

$506K

480
400 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

MANSHA KAHLOON MD

Interventional Cardiology

9,971

$416K

625
451 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $58

STEVE LIN MD

Interventional Cardiology

9,806

$555K

769
626 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

HIMACHALA VELIGANDLA M.D.

Interventional Cardiology

8,959

$289K

794
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $58

KALIDAS SAHETYA MD

Interventional Cardiology

8,457

$558K

752
611 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $58

ANANTH KUMAR M.D.

Interventional Cardiology

7,986

$416K

560
414 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

MUKESH GUPTA MD

Interventional Cardiology

7,799

$346K

653
522 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

JAMES GWINN M.D.

Interventional Cardiology

6,643

$438K

619
516 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $58

MARK JORDAN M.D.

Interventional Cardiology

6,519

$354K

576
487 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

JONATHAN WALTMAN MD

Interventional Cardiology

5,832

$347K

623
528 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $58

ALBERT MERCER M.D.

Interventional Cardiology

5,660

$250K

784
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

JAMES FORD M.D.

Interventional Cardiology

5,145

$428K

516
434 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $58

SANDEEP CHHABRA M.D.

Interventional Cardiology

4,891

$217K

487
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

WILLIAM DILLON MD

Interventional Cardiology

4,823

$339K

508
468 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $58

STEVEN FILARDO M.D.

Interventional Cardiology

4,523

$209K

377
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $58

ROSHAN MATHEW M.D.

Interventional Cardiology

4,334

$200K

798
666 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $58

ANIL SHARMA MD

Interventional Cardiology

4,272

$280K

467
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $58

MOHAMMED KAZIMUDDIN MD FACC FSCAI

Interventional Cardiology

4,229

$187K

426
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

DAVID CASSIDY MD

Interventional Cardiology

3,639

$188K

336
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank